02/2026
On February 26th, our Head of R&D, Ingrid Rauter, and CEO, Martin Munte, were pleased to attend…
02/2026
Our CEO Martin Munte participated in the MeetAustria26 event on invitation of Austrian Business Agency, which…
01/2026
Vaccentis is proud to see the interview of Prof. Dr. med. Martin Marszalek in KURIER Medienhaus adressing the unmed…
01/2026
Our CEO, Martin Munte and our Head of R&D and CMO, Ingrid Rauter, attended the New Year’s reception…
12/2025
Vaccentis is pleased to announce that Matt Regan and Dr Seng Chin Mah have recently…
10/2025
On 24 October 2025, Vaccentis hosted an information event in Zurich for shareholders and investors,…
10/2025
Vaccentis goes Vienna – New EU Hub opens in the Seestadt biotech cluster! We are…
10/2025
Vaccentis is pleased to announce the signing of a letter of intent for a strategic…
09/2025
It offered a great chance for Vaccentis President of the Board Matthias Oertle, CEO Martin…
09/2025
It was a great opportunity for Vaccentis CEO Martin Munte and Head of R&D and…
07/2025
We are delighted to announce that Patrik Grandits has joined the Vaccentis AG Board of Directors! With…
06/2025
On June 17th we held our Annual General Meeting in Zürich. We presented our strategic…
06/2025
The Vaccentis roadshow with 8 Hours Ahead in Hong Kong and China in May 2025…
05/2025
Vaccentis is very pleased to announce the collaboration with Krems Bioanalytics! Together with our Head…
05/2025
It was a great opportunity for Vaccentis to present the company's focus areas in the…
